Literature DB >> 18031701

The hunt for drugs to modify Alzheimer's disease.

James Butcher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18031701     DOI： 10.1016/S1474-4422(07)70280-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  6 in total

Review 1.  Why so few drugs for Alzheimer's disease? Are methods failing drugs?

Authors:  R E Becker; N H Greig
Journal:  Curr Alzheimer Res       Date:  2010-11       Impact factor: 3.498

Review 2.  Lost in translation: neuropsychiatric drug development.

Authors:  Robert E Becker; Nigel H Greig
Journal:  Sci Transl Med       Date:  2010-12-08       Impact factor: 17.956

Review 3.  Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?

Authors:  Robert E Becker; Nigel H Greig; Ezio Giacobini
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

4.  Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?

Authors:  Robert E Becker; Nigel H Greig
Journal:  J Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.153

Review 5.  Alzheimer's disease drug development: old problems require new priorities.

Authors:  Robert E Becker; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-12       Impact factor: 4.388

6.  Intratarget Microdosing for Deep Phenotyping of Multiple Drug Effects in the Live Brain.

Authors:  Jennifer Kim; Sebastian W Ahn; Kyle Deans; Devon Thompson; Benjamin Ferland; Prajan Divakar; Christine Dominas; Oliver Jonas
Journal:  Front Bioeng Biotechnol       Date:  2022-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.